Advertisement
U.S. markets closed

Anika Therapeutics, Inc. (ANIK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
25.14+0.86 (+3.54%)
At close: 04:00PM EST
25.14 0.00 (0.00%)
After hours: 08:00PM EST
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
Total Revenue
163,313
156,236
147,794
130,457
Cost of Revenue
62,423
62,660
64,851
61,431
Gross Profit
100,890
93,576
82,943
69,026
Operating Expense
131,415
112,976
101,423
83,494
Operating Income
-30,525
-19,400
-18,480
-14,468
Net Non Operating Interest Income Expense
2,011
654
-188
-302
Other Income Expense
-
-
21,095
-13,854
Pretax Income
-28,514
-18,746
2,427
-28,624
Tax Provision
-3,939
-3,887
-1,707
-4,642
Net Income Common Stockholders
-24,575
-14,859
4,134
-23,982
Diluted NI Available to Com Stockholders
-24,575
-14,859
4,134
-23,982
Basic EPS
-1.68
-1.02
0.29
-1.69
Diluted EPS
-1.68
-1.02
0.28
-1.69
Basic Average Shares
14,649
14,561
14,401
14,222
Diluted Average Shares
14,649
14,561
14,634
14,222
Total Operating Income as Reported
-30,525
-19,400
2,615
-28,322
Total Expenses
193,838
175,636
166,274
144,925
Net Income from Continuing & Discontinued Operation
-24,575
-14,859
4,134
-23,982
Normalized Income
-24,575
-14,859
-11,265
-12,372
Net Interest Income
2,011
654
-188
-302
EBIT
-30,525
-19,400
-18,480
-14,468
EBITDA
-16,216
-4,913
-4,163
-1,004
Reconciled Cost of Revenue
62,423
62,660
64,851
61,431
Reconciled Depreciation
14,309
14,487
14,317
13,464
Net Income from Continuing Operation Net Minority Interest
-24,575
-14,859
4,134
-23,982
Total Unusual Items Excluding Goodwill
0
0
21,095
-13,854
Total Unusual Items
0
0
21,095
-13,854
Normalized EBITDA
-16,216
-4,913
-25,258
12,850
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
5,696
-2,244